These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 27654286)

  • 1. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
    J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.
    Strokappe N; Szynol A; Aasa-Chapman M; Gorlani A; Forsman Quigley A; Hulsik DL; Chen L; Weiss R; de Haard H; Verrips T
    PLoS One; 2012; 7(3):e33298. PubMed ID: 22438910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of HIV-resistant cells with a single-domain antibody: implications for HIV-1 gene therapy.
    Jin H; Tang X; Li L; Chen Y; Zhu Y; Chong H; He Y
    Cell Mol Immunol; 2021 Mar; 18(3):660-674. PubMed ID: 33462383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites.
    Acharya P; Luongo TS; Georgiev IS; Matz J; Schmidt SD; Louder MK; Kessler P; Yang Y; McKee K; O'Dell S; Chen L; Baty D; Chames P; Martin L; Mascola JR; Kwong PD
    J Virol; 2013 Sep; 87(18):10173-81. PubMed ID: 23843638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.
    Wen M; Arora R; Wang H; Liu L; Kimata JT; Zhou P
    Retrovirology; 2010 Oct; 7():79. PubMed ID: 20923574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
    Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy.
    Chen Y; Jin H; Tang X; Li L; Geng X; Zhu Y; Chong H; He Y
    Emerg Microbes Infect; 2022 Dec; 11(1):30-49. PubMed ID: 34821542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor.
    Liu L; Wen M; Zhu Q; Kimata JT; Zhou P
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):601-10. PubMed ID: 27155865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through
    Wang W; Truong K; Ye C; Sharma S; He H; Liu L; Wen M; Misra A; Zhou P; Kimata JT
    Front Immunol; 2023; 14():1167965. PubMed ID: 37781368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.
    Forsman A; Beirnaert E; Aasa-Chapman MM; Hoorelbeke B; Hijazi K; Koh W; Tack V; Szynol A; Kelly C; McKnight A; Verrips T; de Haard H; Weiss RA
    J Virol; 2008 Dec; 82(24):12069-81. PubMed ID: 18842738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.
    Liu L; Wen M; Wang W; Wang S; Yang L; Liu Y; Qian M; Zhang L; Shao Y; Kimata JT; Zhou P
    J Virol; 2011 Sep; 85(17):8467-76. PubMed ID: 21715497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
    Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
    Front Immunol; 2018; 9():3163. PubMed ID: 30697215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.
    McCoy LE; Quigley AF; Strokappe NM; Bulmer-Thomas B; Seaman MS; Mortier D; Rutten L; Chander N; Edwards CJ; Ketteler R; Davis D; Verrips T; Weiss RA
    J Exp Med; 2012 Jun; 209(6):1091-103. PubMed ID: 22641382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1.
    McCoy LE; Rutten L; Frampton D; Anderson I; Granger L; Bashford-Rogers R; Dekkers G; Strokappe NM; Seaman MS; Koh W; Grippo V; Kliche A; Verrips T; Kellam P; Fassati A; Weiss RA
    PLoS Pathog; 2014 Dec; 10(12):e1004552. PubMed ID: 25522326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
    Popik W; Alce TM; Au WC
    J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    Misra A; Gleeson E; Wang W; Ye C; Zhou P; Kimata JT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eCD4-Ig Variants That More Potently Neutralize HIV-1.
    Fetzer I; Gardner MR; Davis-Gardner ME; Prasad NR; Alfant B; Weber JA; Farzan M
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.
    McCoy LE; Groppelli E; Blanchetot C; de Haard H; Verrips T; Rutten L; Weiss RA; Jolly C
    Retrovirology; 2014 Oct; 11():83. PubMed ID: 25700025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.